Conner: Tell us about the new recommendations for the pneumonia vaccine.

格隆汇12月24日丨建设工业(002265.SZ)在投资者互动平台表示，文创产品是公司半剖浮雕系列文创产品之一。目前文创产品营收占比非常小。

SNY begins phase III study for its 21-valent pneumococcal conjugate vaccine for treating invasive pneumococcal disease in ...

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...

SK bioscience and Sanofi, a global healthcare company, extended their partnership to co-develop next-generation pneumococcal ...

SK Bioscience and global pharmaceutical giant Sanofi signed an expanded agreement to jointly develop next-generation ...

Goldman Sachs rates Vaxcyte a buy with $135 price target, highlighting vaccine platform and pneumonia candidate. Read more ...

根据高盛的说法，Vaxcyte的主打资产VAX-31的风险已经大大降低，这增强了对其监管进展和重大全球商业机会潜力的信心。高盛对Vaxcyte的展望包括扩大公司价值主张的潜力，预计管线资产的出现将创造持久长期增长的机会。

证券之星消息，截至2024年12月19日收盘，民生健康(301507)报收于13.52元，上涨0.3%，换手率4.21%，成交量4.65万手，成交额6219.95万元。

Prioritizing disease prevention naturally requires implementing effective immunization campaigns while also fostering an ...

"I don't want to die young," Mr Ogina said of the impact of the barite mines on him and his family. "I plead with the government to do something urgently." ...